Retatrutide Research Highlights (2026) Obesity Research A phase 2 trial in 338 adults with obesity or overweight showed dose-dependent weight loss
Dietary approaches emphasising whole grains, lean proteins, vegetables, and healthy fatswhilst limiting refined carbohydrates and processed foodshave demonstrated benefit
In fact, some early studies and patient reports indicate bloating and abdominal discomfort improve on GLP-1 therapy, likely due to the slowed, more gradual digestive process
GLP-1 (Glucagon-Like Peptide-1) is a hormone naturally produced in the body
The nausea that felt overwhelming after your first injection at a new dose often becomes much more manageable by your third or fourth injection at that same level
Insured lives and annuitants typically come from a higher average socioeconomic group than the general population and generally are expected to have a lower average BMI